EMMA:OTC-Emmaus Life Sciences Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.1

Change

0.00 (0.00)%

Market Cap

USD 5.70M

Volume

0.01M

Analyst Target

USD 24.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
NONOF Novo Nordisk A/S

-2.47 (-1.68%)

USD 649.39B
CMXHF CSL Limited

-1.79 (-0.93%)

USD 94.38B
CSLLY CSL Ltd

-0.44 (-0.45%)

USD 92.66B
UCBJY UCB SA ADR

-1.18 (-1.58%)

USD 27.94B
UCBJF UCB SA

N/A

USD 26.91B
ARGNF argenx SE

N/A

USD 23.04B
GNMSF Genmab A/S

+3.36 (+1.32%)

USD 17.89B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 6.87B
REGMF RemeGen Co. Ltd

N/A

USD 6.81B
IVBIY IVBIY

N/A

USD 6.79B

ETFs Containing EMMA

XLF Financial Select Sector S.. 6.56 % 0.13 %

+0.22 (+-0.37%)

USD 38.02B
SXLF:LSE SPDR S&P U.S. Financials .. 6.45 % 0.00 %

+0.01 (+-0.37%)

USD 0.37B
IYJ 6.29 % 0.42 %

N/A

N/A
IVFGC 5.90 % 0.00 %

N/A

N/A
VFH Vanguard Financials Index.. 5.58 % 0.10 %

+0.62 (+-0.37%)

USD 9.02B
PFI Invesco DWA Financial Mom.. 5.39 % 0.60 %

+0.29 (+-0.37%)

USD 0.06B
ZFIN:CA 5.14 % 0.00 %

N/A

N/A
BFIN-U:CA 5.12 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 5.06 % 0.00 %

N/A

CAD 3.80M
ZINN:CA 5.05 % 0.00 %

N/A

N/A
VSLU ETF Opportunities Trust -.. 4.87 % 0.00 %

-0.06 (-0.37%)

USD 0.16B
BGU:CA Bristol Gate Concentrated.. 4.84 % 0.85 %

-0.40 (-0.37%)

CAD 0.11B
FINZ 4.83 % 0.95 %

N/A

N/A
SEF ProShares Short Financial.. 4.83 % 0.95 %

-0.06 (-0.37%)

USD 0.01B
SKF ProShares UltraShort Fina.. 4.83 % 0.95 %

-0.16 (-0.37%)

USD 0.01B
TPAY 4.68 % 0.00 %

N/A

N/A
ZINT:CA 4.39 % 0.00 %

N/A

N/A
SPHQ Invesco S&P 500® Quality.. 4.35 % 0.19 %

-0.42 (-0.37%)

USD 9.91B
RUD:CA RBC Quant US Dividend Lea.. 4.30 % 0.43 %

-0.49 (-0.37%)

CAD 0.53B
JOYY 4.26 % 0.00 %

N/A

N/A
HAU:CA 4.23 % 0.79 %

N/A

N/A
SXQG 6 Meridian Quality Growth.. 4.12 % 0.00 %

-0.11 (-0.37%)

USD 0.04B
UYG ProShares Ultra Financial.. 4.05 % 0.95 %

+0.69 (+-0.37%)

USD 0.65B
LINK:CA 4.02 % 0.00 %

N/A

N/A
WBIG WBI BullBear Yield 3000 E.. 3.92 % 1.04 %

-0.06 (-0.37%)

USD 0.04B
HFT:CA 3.89 % 0.00 %

N/A

N/A
ETHI:CA Global X Global Sustainab.. 3.80 % 0.74 %

+0.12 (+-0.37%)

CAD 0.11B
QUAL 3.77 % 0.15 %

N/A

N/A
SIZE iShares MSCI USA Size Fac.. 3.77 % 0.15 %

-0.14 (-0.37%)

USD 0.30B
XDWF:LSE db x-trackers MSCI World .. 3.75 % 0.00 %

+0.07 (+-0.37%)

USD 0.62B
WFIN:LSE SPDR® MSCI World Financi.. 3.74 % 0.00 %

+0.07 (+-0.37%)

USD 0.33B
STNC Stance Equity ESG Large C.. 3.68 % 0.00 %

-0.04 (-0.37%)

USD 0.11B
QMJ 3.66 % 0.00 %

N/A

N/A
DUAL 3.48 % 0.00 %

N/A

N/A
ZUQ:CA BMO MSCI USA High Quality 3.45 % 0.32 %

-0.71 (-0.37%)

CAD 0.82B
PQVM:LSE Invesco S&P 500 QVM UCITS.. 3.23 % 0.00 %

+0.01 (+-0.37%)

USD 0.03B
OUSA 3.15 % 0.48 %

N/A

N/A
VEGN 3.08 % 0.00 %

N/A

N/A
HAU-U:CA 3.00 % 0.00 %

N/A

N/A
JHMF 2.96 % 0.47 %

N/A

N/A
USMC Principal U.S. Mega-Cap E.. 2.85 % 0.12 %

-0.04 (-0.37%)

USD 2.45B
PDP Invesco DWA Momentum ETF 2.59 % 0.62 %

-0.94 (-0.37%)

USD 1.23B
OPPX 2.37 % 0.00 %

N/A

N/A
IWQU:LSE iShares MSCI World Qualit.. 2.27 % 0.00 %

+0.13 (+-0.37%)

USD 3.79B
VIG Vanguard Dividend Appreci.. 2.15 % 0.06 %

N/A

USD 78.38B
XDEQ:LSE Xtrackers MSCI World Qual.. 2.10 % 0.00 %

+25.50 (+-0.37%)

USD 1.70B
PFM Invesco Dividend Achiever.. 1.95 % 0.54 %

+0.05 (+-0.37%)

USD 0.65B
CAPS:CA 1.85 % 0.96 %

N/A

N/A
IGSG:LSE iShares Dow Jones Global .. 1.83 % 0.00 %

+32.50 (+-0.37%)

USD 1.30B
IGSU:LSE iShares Dow Jones Global .. 1.83 % 0.00 %

+0.21 (+-0.37%)

USD 1.30B
RUE-U:CA 1.82 % 0.00 %

N/A

N/A
FLGE 1.79 % 0.00 %

N/A

N/A
XULR:CA 1.72 % 0.00 %

N/A

N/A
QUS:CA QuantShares Enhanced Core.. 1.70 % 0.45 %

-0.09 (-0.37%)

CAD 0.16B
QUS SPDR® MSCI USA Strategic.. 1.56 % 0.15 %

+0.08 (+-0.37%)

USD 1.29B
SUSL iShares ESG MSCI USA Lead.. 1.49 % 0.00 %

-0.20 (-0.37%)

USD 1.01B
QRFT QRAFT AI-Enhanced U.S. La.. 1.46 % 0.00 %

-0.02 (-0.37%)

USD 9.95M
FUSA:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

-0.01 (-0.37%)

USD 0.35B
FUSI:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

+2.50 (+-0.37%)

USD 1.10B
FUQA:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

+2.75 (+-0.37%)

USD 0.35B
FUSD:LSE Fidelity UCITS SICAV - Fi.. 1.40 % 0.00 %

-0.01 (-0.37%)

USD 1.10B
FUSP:LSE Fidelity US Quality Incom.. 1.40 % 0.00 %

N/A

USD 6.14M
XESW:LSE Xtrackers (IE) Plc - Xtra.. 1.25 % 0.00 %

+0.22 (+-0.37%)

USD 6.61B
RWCD 1.15 % 0.00 %

N/A

N/A
UIQM:XETRA 0.87 % 0.00 %

N/A

N/A
TDV 0.00 % 0.00 %

N/A

N/A
ENOA:F BNP Paribas Easy - MSCI N.. 0.00 % 0.00 %

+0.10 (+-0.37%)

USD 0.17B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -64.17% 33% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.17% 33% F 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -36.62% 13% F 5% F
Dividend Return -36.62% 13% F 5% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.90% 71% C- 58% F
Risk Adjusted Return -89.55% 15% F 7% C-
Market Capitalization 5.70M 45% F 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.